GH Research Highlights Federal Support for Psychedelic Depression Treatments as Phase 3 Readiness Advances
Market Chameleon (Mon, 20-Apr 11:07 AM)
GH Research Poised for Next-Gen Depression Treatment as White House Executive Order Bolsters Psychedelic Therapies Initiative
Market Chameleon (Mon, 20-Apr 9:17 AM)
GH Research’s Phase 2b Success in Depression Marks Major Milestone—$280.7M Cash Runway Backs Phase 3 Ambitions
Market Chameleon (Thu, 5-Mar 9:10 AM)
